Latest Guidance News

TerraCom’s audited FY2026 results turned a previously reported A$45.6 million loss into a A$155.5 million statutory loss after A$103.5 million of non-cash impairments. The auditor highlighted material uncertainty over the company’s ability to continue as a going concern as Blair Athol remains below plan and new funding is not yet fully secured.

Kingsgate Consolidated has converted a full year of Chatree mining into record financial results, with revenue up 77% and net profit reaching A$277.9 million. The balance sheet is stronger, dividends have returned and Nueva Esperanza is moving towards a feasibility decision, but higher waste movement and project execution now replace the turnaround story.

Regis Resources ended the first quarter with $1.28 billion in cash and bullion after producing 83.0koz of gold, despite significant rainfall in September. FY27 production guidance remains unchanged, but the quality of quarterly cash generation will face closer scrutiny when full results arrive.

The FDA says positive results from Neurizon’s HEALEY ALS trial could potentially support traditional approval of NUZ-001, with the study possibly serving as the sole registrational trial. The guidance is conditional, but gives the company a clearer regulatory route ahead of topline results expected in late Q2 2027.

L1 Global Long Short Fund has launched a non-underwritten one-for-two entitlement offer at A$1.76 a share, targeting up to A$482.7 million for new investments. The raising follows a 19.4% portfolio return since L1 Capital became manager and comes with the familiar risk that shareholders who do not participate could be diluted.

Wide Open Agriculture has completed a study for a proposed 10,000-tonne-per-year lupin protein facility with indicative annual revenue of A$240 million to A$295 million. The project remains unfunded, unapproved and years from production, leaving contract manufacturing as the immediate test of the company’s strategy.

Aquirian has completed its Wubin Energetics Hub upgrade within budget and is preparing Drillforce to begin work at Brightstar Resources’ Lord Byron project under a contract valued at approximately $48 million over three years. The company also says Collar Keeper sales remain strong, while a biodegradable version moves towards commercialisation.

Tower has lifted its FY26 underlying NPAT guidance to $69 million-$79 million after large event claims came in below the allowance built into its forecast. Customer growth also remained strong, although customer remediation costs will continue to weigh on reported profit.

Aspen Group delivered a stronger-than-expected first quarter, with net rental income up 16% and realised development profit nearly doubling to $7.9 million. The company maintained its FY27 targets, while warning that weaker economic conditions could disrupt development settlements.

Radiopharm says the FDA has provided a clear framework for the pivotal development of RAD101, its investigational brain metastases imaging agent. The company is preparing for Phase 3 while awaiting formal meeting minutes that could still refine the trial design and regulatory requirements.

Zenith Minerals has rejected an unsolicited $5 million capital-raising proposal from Aurenne, saying it is incomplete, difficult to implement and offers shareholders no direct consideration. The board has kept its recommendation of Forrestania Resources’ takeover offer unchanged.

Capricorn Metals produced 31,218 ounces of gold in the September quarter, while its Karlawinda expansion was completed on schedule and within budget. The enlarged operation is now running at 6.5 million tonnes a year, although the next test is converting that capacity into consistent production and costs.